Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Ci… (NCT00843622) | Clinical Trial Compass
CompletedPhase 4
Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers
United States250 participantsStarted 2009-02
Plain-language summary
The study aims to assess if use of a low-nitrosamine, Swedish, smokefree tobacco product for oral use ("snus") can increase the quit rate among cigarette smokers who wish to stop smoking
Who can participate
Age range25 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Cigarette smoker who smoke more than 9 cigarettes per day (average during past month)
* Daily smoking more than 1 year
* Motivated to quit smoking using a smokefree tobacco product
* Good general health
Exclusion Criteria:
* Use of smokefree/smokeless tobacco during past 6 months or any type of pharmaceutical product for smoking cessation during past 3 months
* Unable to refrain from nicotine replacement therapy during the study
* Current oral condition that could be made worse by study interventions
* History of clinically significant renal, hepatic, neurological, or chronic pulmonary disease that in the judgement of the investigator might preclude participation
* History of significant cardiovascular disease, including myocardial infarction, within the last 3 months, significant cardiac arrythmias, or poorly controlled hypertension that in the judgement of the investigator might preclude participation
* History of alcohol or substance abuse other than cigarette smoking within the past year
What they're measuring
1
Continuous Rate of Smoking Cessation by Self-report and Confirmed by Expired Air Carbon Monoxide Less or Equal Than 8 Ppm